GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
2022-04-25|

DetectedX and GE Healthcare Enter Mammography Education Partnership to Improve Accuracy and Better Inform Clinical Decisions

by GeneOnline
Share To

Radiology Online Learning Centre from DetectedX – Available as Part of the GE Healthcare Clinical Education Program – Has Shown a 34% Improvement in the Accuracy of Diagnosing Difficult Cases

SYDNEY, April 25, 2022 /PRNewswire/ — Fostering global excellence in diagnostic accuracy, DetectedX and GE Healthcare have entered into an educational partnership to expand access to the Radiology Online Learning Platform from DetectedX. Designed to improve radiologists’ ability to correctly detect breast lesions in 2D and 3D Mammography, the online self-assessment modules have been shown to lower recall rates and improve cancer detection by over 34 percent.   

DetectedX was founded to help doctors and radiologists worldwide to diagnose cases of breast cancer, lung cancer, and COVID-19 faster and more accurately. The on-demand, web-based training platform, which improves radiological detection rates based on intelligent interactive educational technology, is currently in use by more than 3,000 users in more than 150 countries.

“Inaccurate or inconsistent readings of mammograms can create unnecessary trauma for patients, can delay treatment and put practices at risk. This variability can be reduced by making high quality education available in an online, on-demand format. Through personalized, CPD & CME-accredited training that uses real cases that include both malignant and normal cases, DetectedX reduces false results and improves diagnostic accuracy,” said Professor Patrick Brennan, CEO DetectedX and Chair, Diagnostic Imaging, University of Sydney.

The learning packages from GE Healthcare leverage DetectedX’s innovative educational technology to enable Radiologists to review, in real time, an enriched cohort of 2D mammography and Digital Breast Tomosynthesis (3D mammography) cases with varying levels of difficulty. The on-demand, online training packages provide immediate feedback on reading performance, comparing the user’s classification to the pathology-verified ground truth for each case. Using several metrics including sensitivity, specificity, true positive, true negative, false positive and false negative scores to gauge their performance, radiologists are able to identify errors and focus future trainings on areas of need to improve performance for earlier and more accurate disease diagnoses. Upon successful completion of each training module, users receive Continuing Medical Education (CME) credits. 

“These education modules will help radiologists improve their ability to consistently identify disease. The DetectedX self-assessment tool fits well in a broad blended learning experience. It allows our users to make the images their own, practicing at their own pace and gaining expertise,” said Sandrine Kerherve, Global Education Manager, GE Healthcare.

ABOUT DETECTEDX

DetectedX’s Radiology Online Learning Centre , focusing on diagnostic accuracy and driven by artificial intelligence, is revolutionizing disease detection in 150 countries. The on-demand, web-based training platform has been proven to improve the accuracy of diagnosing difficult cases by 34%. DetectedX was founded by Professor Patrick Brennan, a leading medical radiation scientist with $40+M in research funding and 500+ publications, Prof. Mary Rickard, Australia’s number one breast imaging clinician expert scientist who pioneered Australia’s Breast Screening program, and Dr. Moe Suleiman, one of the world’s leaders on optimizing radiologic interpretation.

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
2025-01-10
United Imaging Announces Major Expansion of U.S. Manufacturing Space
2025-01-09
Complete Genomics announces mpox virus amplicon sequencing panel at AMP
2024-11-20
LATEST
Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States
2025-02-13
NASA Says There’s a 1 in 43 Chance an Asteroid 2024 YR4 Could Hit Earth in 2032—Should We Worry?
2025-02-13
Sodium Channel Targeting: What the Latest FDA Non-Opioid Approval Reveals About the Next Big Thing in Pain Relief
2025-02-12
Novartis Reclaims Abelacimab in $925M Deal to Boost Cardiovascular Portfolio
2025-02-12
GLP-1 Weight Loss Drugs Might Cause Blindness
2025-02-11
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-04
MIXiii Health-Tech.IL
Jerusalem, Israel
2025-03-05
Medical Japan
Osaka, Japan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
Scroll to Top